Diretrizes de Práticas Clínicas da AGA sobre o tratamento médico da Doença de Crohn fistulizante luminal e perianal moderada a grave
1 Jun, 2021 | 10:11hComunicado de imprensa: AGA recommends early use of biologics in patients with moderate-to-severe Crohn’s disease – American Gastroenterology Association
Revisão técnica: AGA Technical Review on the Medical Management of Moderate to Severe Luminal and Perianal Fistulizing Crohn’s Disease
Ferramenta de apoio à decisão médica / Algoritmo: Medical Management of Adult Outpatients With Moderate to Severe Lunminal Crohn’s Disease
Comentário no Twitter
Here are the @AmerGastroAssn guidelines on the management of moderate-severe Crohn disease. #GITwitter #GI #gut #IBD https://t.co/VlT4xTUE8t pic.twitter.com/ayYlpVkkod
— John Damianos, M.D. (@john_damianosMD) May 28, 2021